Gentherm

US · THRM #2925 by market cap

30.38 -0.62 -2.00%

Live - 5344 symbols - heartbeat 222s ago · 2026-10-08 09:18

Pre-market 30.38 0.00%

After-hours 30.20 -0.59%

Overnight 30.07 -1.02%

Market cap: 1.65B
P/E (TTM): 35.33
P/B: 2.29
EPS: 0.59
Div yield: 0.00%
52W pos: 25%

Reader sentiment Are you bullish or bearish on THRM?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 3.81, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +2.92% YoY

Margins

Gross margin: 24.17%
Operating margin: 6.50%
Net margin: 1.22%

Key ratios & quality

Enterprise value: 1.69B
Altman Z-Score: 3.81

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	1.05B	971.68M	913.10M	1.05B	1.20B	1.47B	1.46B	1.50B
Gross profit	304.86M	288.34M	268.10M	303.63M	273.65M	351.62M	366.43M	362.18M
Selling & admin expenses	137.40M	118.68M	105.04M	109.55M	132.69M	155.58M	155.11M	170.05M
Research & development	79.90M	72.48M	68.04M	75.21M	85.72M	94.36M	88.70M	94.76M
Operating profit	87.56M	97.18M	95.02M	118.86M	55.24M	101.69M	122.63M	97.37M
Pretax profit	58.12M	59.15M	81.56M	113.85M	38.38M	54.95M	102.27M	35.84M
Tax	16.22M	10.29M	21.87M	20.42M	13.94M	14.61M	37.32M	17.55M
Net profit	41.90M	48.87M	59.69M	93.43M	24.44M	40.34M	64.95M	18.29M
Basic EPS	1	1	2	3	1	1	2	1
Diluted EPS	1.16	1.47	1.81	2.79	0.73	1.22	2.06	0.59

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	353.85M	375.09M	386.87M	382.79M	393.71M	416.17M
Gross profit	86.47M	89.76M	95.15M	90.80M	97.23M	96.43M
Selling & admin expenses	38.48M	41.09M	42.88M	47.61M	55.31M	55.71M
Research & development	24.22M	22.56M	24.43M	23.56M	23.95M	24.07M
Operating profit	23.77M	26.12M	27.84M	19.64M	17.98M	16.65M
Pretax profit	2.08M	2.53M	20.88M	10.33M	7.61M	7.32M
Tax	2.21M	2.06M	5.94M	7.35M	3.40M	2.90M
Net profit	-128.00K	477.00K	14.95M	2.99M	4.22M	4.42M
Basic EPS	0	0	0	0	0	0
Diluted EPS	0.00	0.02	0.49	0.10	0.14	0.14

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	443.08M	373.86M	643.61M	565.85M	683.87M	687.56M	684.02M	776.95M
Cash & ST investments	39.62M	50.44M	268.35M	190.61M	153.89M	149.67M	134.13M	160.83M
Inventory	112.54M	118.48M	122.40M	159.48M	218.25M	205.89M	227.36M	252.70M
Total assets	803.05M	738.83M	1.02B	935.34M	1.24B	1.23B	1.25B	1.40B
Total current liabilities	175.40M	156.70M	205.98M	213.09M	285.63M	324.95M	340.29M	404.31M
Short-term debt	3.41M	7.09M	8.53M	8.17M	9.59M	8.32M	7.65M	9.72M
Long-term debt	136.48M	78.12M	189.93M	36.25M	232.65M	222.22M	220.06M	189.00M
Total liabilities	323,348,000.00	254,736,000.00	436,508,000.00	281,537,000.00	567,027,000.00	589,649,000.00	630,609,000.00	676,106,000.00
Total equity	479.70M	484.10M	586.33M	653.81M	672.27M	644.72M	616.95M	720.32M
Retained earnings	363.97M	413.09M	472.78M	566.22M	590.66M	624.38M	695.80M	714.09M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	764.04M	758.82M	785.89M	776.95M	826.20M	880.01M
Cash & ST investments	163.14M	128.30M	154.25M	160.83M	177.40M	213.17M
Inventory	235.99M	248.38M	253.25M	252.70M	256.97M	244.54M
Total assets	1.34B	1.36B	1.38B	1.40B	1.43B	1.49B
Total current liabilities	353.23M	376.93M	400.33M	404.31M	418.43M	426.28M
Short-term debt	9.67M	10.06M	10.29M	9.72M	9.14M	9.07M
Long-term debt	262.03M	209.00M	189.00M	189.00M	219.00M	272.39M
Total liabilities	697,718,000.00	661,656,000.00	663,387,000.00	676,106,000.00	713,824,000.00	770,086,000.00
Total equity	646.53M	699.75M	717.95M	720.32M	716.47M	723.12M
Retained earnings	695.67M	696.15M	711.10M	714.09M	718.30M	722.72M

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	118.43M	118.80M	110.70M	143.08M	14.95M	119.27M	109.65M	116.79M
Depreciation & amortization	50.64M	44.25M	41.11M	38.78M	44.39M	50.95M	52.98M	53.38M
Free cash flow	76.89M	95.07M	90.34M	97.05M	-25.25M	80.85M	35.38M	59.88M
Dividends paid	--	--	--	--	--	--	--	--
Stock buybacks / issuance	-149.26M	-64.69M	-9.09M	-20.00M	0	-91.09M	-51.59M	-10.02M
Ending cash balance	39.62M	52.95M	268.35M	190.61M	153.89M	149.67M	134.13M	160.83M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	-13.34M	45.05M	56.12M	28.97M	-5.04M	7.32M
Depreciation & amortization	12.93M	13.16M	13.39M	13.90M	14.22M	14.52M
Free cash flow	-28.37M	35.75M	46.14M	6.35M	-10.69M	-1.49M
Dividends paid	--	--	--	--	--	--
Stock buybacks / issuance	--	--	0	0	--	--
Ending cash balance	163.14M	128.30M	154.25M	160.83M	177.40M	213.17M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	8.11	7.88	11.27	15.07	3.69	6.13	10.30	2.73
ROA %	4.97	4.90	6.82	9.54	2.25	3.26	5.23	1.38
ROIC %	6.90	6.84	9.18	12.53	3.29	5.59	8.42	3.09
5-year avg ROE %	17.59	14.29	10.90	10.28	9.63	9.23	9.27	7.58
EBIT margin %	6.07	6.58	9.43	11.15	3.54	4.74	8.07	3.31
FCF / sales %	7.41	9.78	9.89	9.28	--	5.50	2.43	4.00
Current ratio	2.53	2.39	3.12	2.66	2.39	2.12	2.01	1.92
Quick ratio	1.40	1.51	2.47	1.86	1.52	1.36	1.25	1.19
Debt / assets	17.42	12.45	21.77	6.86	21.20	19.99	21.22	17.68
LT debt / equity	28.45	17.53	36.53	8.57	37.66	36.98	41.68	32.92
Interest coverage	12.76	13.42	18.89	42.28	9.94	4.75	7.68	3.59
Revenue CAGR (3Y) %	6.98	1.93	-2.79	-0.07	7.43	17.18	11.65	7.55
Net income CAGR (3Y) %	-23.99	-13.91	19.22	30.65	-20.62	-12.24	-11.42	-9.22
FCF CAGR (3Y) %	16.03	31.21	--	8.07	--	-3.63	-28.57	--

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	7.74	4.72	4.44	2.73	3.32	3.74
ROA %	3.85	2.43	2.29	1.38	1.63	1.86
ROIC %	6.60	4.65	4.39	3.09	3.10	3.36
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	6.99	5.21	5.17	3.31	3.53	3.69
FCF / sales %	1.99	3.23	4.55	4.00	5.04	2.55
Current ratio	2.16	2.01	1.96	1.92	1.97	2.06
Quick ratio	1.38	1.22	1.20	1.19	1.25	1.37
Debt / assets	23.99	19.85	18.02	17.68	19.12	21.77
LT debt / equity	48.39	37.18	33.24	32.92	36.89	43.70
Interest coverage	6.51	4.84	5.32	3.59	4.21	4.80
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Single-engine

Automotive is the largest reported line at 97.27% of revenue, across 2 reported segments.
The next-largest line, Medical, is a distant second at 2.73% - a sharp slowdown here would have little to offset it.

Revenue breakdown most recent period

Business

Automotive97.27%

Medical2.73%

Quote time 2026-10-08 09:18:24 · For reference only, not investment advice and not tailored to your situation.